SEC Form SC 13G/A filed by Lifevantage Corporation (Amendment)
$LFVN
Biotechnology: Pharmaceutical Preparations
Health Care
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
1/14/2025 | $35.00 | Buy | Craig Hallum |
12/19/2024 | $26.00 | Buy | Lake Street |